LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 166

Search options

  1. Article ; Online: Gut microbiota lends a helping hand to nurse liver regeneration.

    Yeoh, Beng San / Vijay-Kumar, Matam

    Journal of hepatology

    2023  Volume 78, Issue 4, Page(s) 681–683

    MeSH term(s) Humans ; Gastrointestinal Microbiome ; Liver Regeneration ; Liver ; Microbiota ; Focal Nodular Hyperplasia
    Language English
    Publishing date 2023-01-27
    Publishing country Netherlands
    Document type Editorial ; Research Support, N.I.H., Extramural ; Comment
    ZDB-ID 605953-3
    ISSN 1600-0641 ; 0168-8278
    ISSN (online) 1600-0641
    ISSN 0168-8278
    DOI 10.1016/j.jhep.2023.01.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Eat more natural dietary fiber and whole grains to minimize liver disease risk.

    Golonka, Rachel M / Yeoh, Beng San / Vijay-Kumar, Matam

    Hepatobiliary surgery and nutrition

    2022  Volume 11, Issue 4, Page(s) 601–604

    Language English
    Publishing date 2022-08-04
    Publishing country China (Republic : 1949- )
    Document type Editorial ; Comment
    ZDB-ID 2812398-0
    ISSN 2304-389X ; 2304-3881
    ISSN (online) 2304-389X
    ISSN 2304-3881
    DOI 10.21037/hbsn-22-155
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Invited Perspective: PFOS-Pick Fiber, Oust Sulfonate.

    Golonka, Rachel M / Vijay-Kumar, Matam

    Environmental health perspectives

    2022  Volume 130, Issue 11, Page(s) 111301

    MeSH term(s) Alkanesulfonic Acids ; Fluorocarbons ; Alkanesulfonates
    Chemical Substances Alkanesulfonic Acids ; Fluorocarbons ; Alkanesulfonates
    Language English
    Publishing date 2022-11-04
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 195189-0
    ISSN 1552-9924 ; 0091-6765 ; 1078-0475
    ISSN (online) 1552-9924
    ISSN 0091-6765 ; 1078-0475
    DOI 10.1289/EHP12012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Hypertension Increases Susceptibility to Experimental Malaria in Mice.

    Kandalgaonkar, Mrunmayee R / Yeoh, Beng San / Joe, Bina / Schmidt, Nathan W / Vijay-Kumar, Matam / Saha, Piu

    Function (Oxford, England)

    2024  Volume 5, Issue 3, Page(s) zqae009

    Abstract: Global prevalence of hypertension is on the rise, burdening healthcare, especially in developing countries where infectious diseases, such as malaria, are also rampant. Whether hypertension could predispose or increase susceptibility to malaria, however, ...

    Abstract Global prevalence of hypertension is on the rise, burdening healthcare, especially in developing countries where infectious diseases, such as malaria, are also rampant. Whether hypertension could predispose or increase susceptibility to malaria, however, has not been extensively explored. Previously, we reported that hypertension is associated with abnormal red blood cell (RBC) physiology and anemia. Since RBC are target host cells for malarial parasite,
    MeSH term(s) Animals ; Malaria/immunology ; Malaria/parasitology ; Malaria/complications ; Malaria/blood ; Malaria/physiopathology ; Plasmodium yoelii ; Mice ; Hypertension ; Erythrocytes/parasitology ; Erythrocytes/metabolism ; Disease Susceptibility ; Male ; Anemia/parasitology ; Disease Models, Animal ; Hemolysis
    Language English
    Publishing date 2024-02-28
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ISSN 2633-8823
    ISSN (online) 2633-8823
    DOI 10.1093/function/zqae009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Beneficial and detrimental effects of processed dietary fibers on intestinal and liver health: health benefits of refined dietary fibers need to be redefined!

    Singh, Vishal / Vijay-Kumar, Matam

    Gastroenterology report

    2020  Volume 8, Issue 2, Page(s) 85–89

    Abstract: Consumption of processed foods-which are generally composed of nutritionally starved refined ingredients-has increased exponentially worldwide. A rise in public health awareness that low fiber intake is strongly linked to new-age disorders has spurred ... ...

    Abstract Consumption of processed foods-which are generally composed of nutritionally starved refined ingredients-has increased exponentially worldwide. A rise in public health awareness that low fiber intake is strongly linked to new-age disorders has spurred food manufacturers to fortify processed foods with refined dietary fibers (RDFs). Consumption of whole foods rich in natural fibers undoubtedly confers an array of health benefits. However, it is not clear whether RDFs extracted from the whole plant, kernel, and fruit peels exert similar physiological effects to their naturally occurring counterparts. Recent studies caution that RDFs are not universally beneficial and that inappropriate consumption of RDFs may risk both gastrointestinal and liver health. Herein, we briefly summarize the beneficial and detrimental effects of RDFs on digestive health and discuss the contribution of metabolites derived from microbial fermentation of RDFs in driving such positive or negative health outcomes.
    Language English
    Publishing date 2020-01-20
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2710871-5
    ISSN 2052-0034
    ISSN 2052-0034
    DOI 10.1093/gastro/goz072
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Bacterial flagellin is a dominant, stable innate immune activator in the gastrointestinal contents of mice and rats.

    Vijay-Kumar, Matam / Bovilla, Venugopal R / Yeoh, Beng San / Golonka, Rachel M / Saha, Piu / Joe, Bina / Gewirtz, Andrew T

    Gut microbes

    2023  Volume 15, Issue 1, Page(s) 2185031

    Abstract: Intestinal contents comprise the largest repository of immunogenic ligands of microbial origin. We undertook this study to assess the predominant microbe-associated molecular patterns (MAMPs) present therein and the receptors) that mediate the innate ... ...

    Abstract Intestinal contents comprise the largest repository of immunogenic ligands of microbial origin. We undertook this study to assess the predominant microbe-associated molecular patterns (MAMPs) present therein and the receptors) that mediate the innate immune responses to them. Here, we demonstrated that intestinal contents from conventional, but not germ-free, mice and rats triggered robust innate immune responses
    MeSH term(s) Animals ; Rats ; Gastrointestinal Contents ; Flagellin ; Gastrointestinal Microbiome ; Flagella ; Immunity, Innate
    Chemical Substances Flagellin (12777-81-0)
    Language English
    Publishing date 2023-03-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2575755-6
    ISSN 1949-0984 ; 1949-0984
    ISSN (online) 1949-0984
    ISSN 1949-0984
    DOI 10.1080/19490976.2023.2185031
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Prospects for Leveraging the Microbiota as Medicine for Hypertension.

    Durgan, David J / Zubcevic, Jasenka / Vijay-Kumar, Matam / Yang, Tao / Manandhar, Ishan / Aryal, Sachin / Muralitharan, Rikeish R / Li, Hong-Bao / Li, Ying / Abais-Battad, Justine M / Pluznick, Jennifer L / Muller, Dominik N / Marques, Francine Z / Joe, Bina

    Hypertension (Dallas, Tex. : 1979)

    2024  Volume 81, Issue 5, Page(s) 951–963

    MeSH term(s) Humans ; Hypertension ; Blood Pressure ; Microbiota
    Language English
    Publishing date 2024-04-17
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 423736-5
    ISSN 1524-4563 ; 0194-911X ; 0362-4323
    ISSN (online) 1524-4563
    ISSN 0194-911X ; 0362-4323
    DOI 10.1161/HYPERTENSIONAHA.124.21721
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome.

    Golonka, Rachel M / Vijay-Kumar, Matam

    Advances in cancer research

    2020  Volume 149, Page(s) 171–255

    Abstract: Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality worldwide. Much recent research has delved into understanding the underlying molecular mechanisms of HCC pathogenesis, which has revealed to be heterogenous and ... ...

    Abstract Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality worldwide. Much recent research has delved into understanding the underlying molecular mechanisms of HCC pathogenesis, which has revealed to be heterogenous and complex. Two major hallmarks of HCC include: (i) a hijacked immunometabolism and (ii) a reprogramming in metabolic processes. We posit that the gut microbiota is a third component in an entanglement triangle contributing to HCC progression. Besides metagenomic studies highlighting the diagnostic potential in the gut microbiota profile, recent research is pinpointing the gut microbiota as an instigator, not just a mere bystander, in HCC. In this chapter, we discuss mechanistic insights on atypical immunometabolism and metabolic reprogramming in HCC, including the examination of tumor-associated macrophages and neutrophils, tumor-infiltrating lymphocytes (e.g., T-cell exhaustion, regulatory T-cells, natural killer T-cells), the Warburg effect, rewiring of the tricarboxylic acid cycle, and glutamine addiction. We further discuss the potential involvement of the gut microbiota in these characteristics of hepatocarcinogenesis. An immediate highlight is that microbiota metabolites (e.g., short chain fatty acids, secondary bile acids) can impair anti-tumor responses, which aggravates HCC. Lastly, we describe the rising 'new era' of immunotherapies (e.g., immune checkpoint inhibitors, adoptive T-cell transfer) and discuss for the potential incorporation of gut microbiota targeted therapeutics (e.g., probiotics, fecal microbiota transplantation) to alleviate HCC. Altogether, this chapter invigorates for continuous research to decipher the role of gut microbiome in HCC from its influence on immunometabolism and metabolic reprogramming.
    MeSH term(s) Animals ; Carcinoma, Hepatocellular/immunology ; Carcinoma, Hepatocellular/metabolism ; Carcinoma, Hepatocellular/microbiology ; Carcinoma, Hepatocellular/pathology ; Gastrointestinal Microbiome ; Humans ; Immune System/immunology ; Liver Neoplasms/immunology ; Liver Neoplasms/metabolism ; Liver Neoplasms/microbiology ; Liver Neoplasms/pathology
    Language English
    Publishing date 2020-11-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 127-2
    ISSN 2162-5557 ; 0065-230X
    ISSN (online) 2162-5557
    ISSN 0065-230X
    DOI 10.1016/bs.acr.2020.10.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Psyllium fiber protects mice against western diet-induced metabolic syndrome via the gut microbiota-dependent mechanism.

    Bretin, Alexis / Yeoh, Beng San / Ngo, Vu L / Reddivari, Lavanya / Pellizzon, Michael / Vijay-Kumar, Matam / Gewirtz, Andrew T

    Gut microbes

    2023  Volume 15, Issue 1, Page(s) 2221095

    Abstract: Impacts of dietary fiber on intestinal inflammation are complex, but some specific semi-purified fibers, particularly psyllium, can protect humans and rodents against colitis. Mechanisms underlying such protection are not fully understood but may involve ...

    Abstract Impacts of dietary fiber on intestinal inflammation are complex, but some specific semi-purified fibers, particularly psyllium, can protect humans and rodents against colitis. Mechanisms underlying such protection are not fully understood but may involve activation of the FXR bile acid receptor. Obesity and its associated consequences, referred to as metabolic syndrome, are associated with, and promoted by, low-grade inflammation in a variety of tissues including the intestine. Hence, we examined whether psyllium might ameliorate the low-grade intestinal inflammation that occurs in diet-induced obesity and, moreover, the extent to which it might ameliorate adiposity and/or dysglycemia in this disease model. We observed that enriching a high-fat diet with psyllium provided strong protection against the low-grade gut inflammation and metabolic consequences that were otherwise induced by the obesogenic diet. Such protection was fully maintained in FXR-deficient mice, indicating that distinct mechanisms mediate psyllium's protection against colitis and metabolic syndrome. Nor did psyllium's protection associate with, or require, fermentation or IL-22 production, both of which are key mediators of beneficial impacts of some other dietary fibers. Psyllium's beneficial impacts were not evident in germfree mice but were observed in Altered Schaedler Flora mice, in which psyllium modestly altered relative and absolute abundance of the small number of taxa present in these gnotobiotic mice. Thus, psyllium protects mice against diet-induced obesity/metabolic syndrome by a mechanism independent of FXR and fermentation but nonetheless requires the presence of at least a minimal microbiota.
    MeSH term(s) Humans ; Animals ; Mice ; Metabolic Syndrome/prevention & control ; Diet, Western ; Gastrointestinal Microbiome ; Psyllium ; Obesity/prevention & control ; Dietary Fiber ; Colitis ; Inflammation
    Chemical Substances Psyllium (8063-16-9) ; Dietary Fiber
    Language English
    Publishing date 2023-06-12
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2575755-6
    ISSN 1949-0984 ; 1949-0984
    ISSN (online) 1949-0984
    ISSN 1949-0984
    DOI 10.1080/19490976.2023.2221095
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy.

    Campbell, Connor / Kandalgaonkar, Mrunmayee R / Golonka, Rachel M / Yeoh, Beng San / Vijay-Kumar, Matam / Saha, Piu

    Biomedicines

    2023  Volume 11, Issue 2

    Abstract: Gut microbes and their metabolites are actively involved in the development and regulation of host immunity, which can influence disease susceptibility. Herein, we review the most recent research advancements in the gut microbiota-immune axis. We discuss ...

    Abstract Gut microbes and their metabolites are actively involved in the development and regulation of host immunity, which can influence disease susceptibility. Herein, we review the most recent research advancements in the gut microbiota-immune axis. We discuss in detail how the gut microbiota is a tipping point for neonatal immune development as indicated by newly uncovered phenomenon, such as maternal imprinting, in utero intestinal metabolome, and weaning reaction. We describe how the gut microbiota shapes both innate and adaptive immunity with emphasis on the metabolites short-chain fatty acids and secondary bile acids. We also comprehensively delineate how disruption in the microbiota-immune axis results in immune-mediated diseases, such as gastrointestinal infections, inflammatory bowel diseases, cardiometabolic disorders (e.g., cardiovascular diseases, diabetes, and hypertension), autoimmunity (e.g., rheumatoid arthritis), hypersensitivity (e.g., asthma and allergies), psychological disorders (e.g., anxiety), and cancer (e.g., colorectal and hepatic). We further encompass the role of fecal microbiota transplantation, probiotics, prebiotics, and dietary polyphenols in reshaping the gut microbiota and their therapeutic potential. Continuing, we examine how the gut microbiota modulates immune therapies, including immune checkpoint inhibitors, JAK inhibitors, and anti-TNF therapies. We lastly mention the current challenges in metagenomics, germ-free models, and microbiota recapitulation to a achieve fundamental understanding for how gut microbiota regulates immunity. Altogether, this review proposes improving immunotherapy efficacy from the perspective of microbiome-targeted interventions.
    Language English
    Publishing date 2023-01-20
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines11020294
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top